Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Oncotarget|October 13, 2016
Germline mutations in Japanese familial pancreatic cancer patientsErina Takai, Shinichi Yachida, Kyoko Shimizu, et al.
Cancer Management and Research|June 26, 2020
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 TrialYasuyoshi Sato, Naoki Fukuda, Xiaofei Wang, et al.
International Journal of Clinical Oncology|April 26, 2024
Availability of genome-matched therapy based on clinical practiceNaomi Hayashi, Seiichi Mori, Akihiro Ohmoto, et al.
Endocrine Journal|January 28, 2021
Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patientsNaoki Fukuda, Kazuhisa Toda, Xiaofei Wang, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 21, 2020
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxelNaoki Fukuda, Yu Fujiwara, Xiaofei Wang, et al.
Anticancer Research|March 31, 2021
Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With LenvatinibNaoki Fukuda, Kazuhisa Toda, Akihiro Ohmoto, et al.
Leukemia & Lymphoma|March 28, 2015
Histopathological analysis of B-cell non-Hodgkin lymphomas without light chain restriction by using flow cytometryAkihiro Ohmoto, Akiko Miyagi Maeshima, Hirokazu Taniguchi, et al.
Journal of Geriatric Oncology|May 25, 2023
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatinYu Fujiwara, Yasuyoshi Sato, Naomi Hayashi, et al.
Neoplasia (New York, N.Y.)|September 11, 2022
Druggable gene alterations in Japanese patients with rare malignancyAkihiro Ohmoto, Naomi Hayashi, Ippei Fukada, et al.
Cancer Reports (Hoboken, N.J.)|December 9, 2020
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patientsNaoki Fukuda, Mayu Yunokawa, Yu Fujiwara, et al.
Pageof 7